1
项与 AAV-LK03.hOTC 相关的临床试验Phase I/II Open Label, Multicentre Clinical Trial to Assess Safety and Efficacy of AAVLK03hOTC for Paediatric Patients With Ornithine Transcarbamylase Deficiency.
Ornithine transcarbamylase deficiency (OTCD) is an inherited metabolic liver disease which means that the body cannot maintain normal levels of ammonia. Ammonia levels can rise (called hyperammonaemic decompensations) which can be life-threatening and may result in impaired neurological development in children. OTCD is a rare genetic disorder characterised by complete or partial lack of the enzyme ornithine transcarbamylase (OTC).
100 项与 AAV-LK03.hOTC 相关的临床结果
100 项与 AAV-LK03.hOTC 相关的转化医学
100 项与 AAV-LK03.hOTC 相关的专利(医药)
100 项与 AAV-LK03.hOTC 相关的药物交易